Revenue
2019
2020
2021
2022
2023
2024
2025
Certara, Inc. (CERT)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $418.8M | $385.1M | $354.3M | $335.6M | $286.1M | $243.5M | $208.5M |
| Research & development | $41.0M | $37.1M | $34.2M | $28.2M | $20.4M | $19.6M | $11.6M |
| Operating expenses | $236.7M | $232.4M | $254.1M | $170.5M | $160.9M | $167.2M | $109.1M |
| Operating income | $21.0M | −$1.7M | −$40.8M | $32.5M | $13.6M | −$24.4M | $19.6M |
| EBITDAderived | $96.2M | $66.3M | $15.3M | $34.3M | $15.7M | −$22.0M | $22.2M |
| Net income | −$1.6M | −$12.1M | −$55.4M | $14.7M | −$13.3M | −$49.4M | −$8.9M |
| Basic EPSper diluted share | -$0.01 | -$0.08 | -$0.35 | $0.09 | -$0.09 | -$0.37 | -$0.07 |
| Diluted EPSper diluted share | -$0.01 | -$0.08 | -$0.35 | $0.09 | -$0.09 | -$0.37 | -$0.07 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 11, 2025Form 4 | Feehery William FCHIEF EXECUTIVE OFFICER | BuyCommon Stock | 24.1K | $8.30 | $200.0K | 2.36M |
| Sep 9, 2025Form 4 · 10b5-1 | Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF | SellCommon Stock | 51.2K | $10.92 | $559.4K | 74.0K |
| Oct 7, 2024Form 4 · 10b5-1 | SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS | SellCommon Stock | 5.4K | $11.03 | $59.7K | 50.1K |
| Sep 9, 2024Form 4 · 10b5-1 | Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF | SellCommon Stock | 51.2K | $11.29 | $578.3K | 99.7K |